 |
|
|
|
 |
 |
Investigator |
 |
Institution |
 |
Project |
 |
|
Krys Bankiewicz, MD PhD |
|
University of California
San Francisco |
|
Convection-Enhanced Delivery of Immunoliposomes
into Brain Tumors Using Real Time MRI |
 |
|
Soonmee Cha, MD
|
|
University of California
San Francisco
|
|
Identification of Prognostic Surrogate Markers in Malignant Gliomas
by Quantitative Magnetic Resonance Imaging
|
 |
|
Charles Conrad, MD and
Jeremy Rich, MD
|
|
MD Anderson
Cancer Center
and
Duke University
|
|
Development of Potential Synergistic Therapies with Small Molecule
Inhibitors of Receptor Tyrosine Kinases, Intracellular Signal
Transduction Elements and Cytotoxic Therapies
|
 |
|
John Fiveash, MD
|
|
University of Alabama
at Birmingham
|
|
Enhancement of Glioma Radiation Therapy and Chemotherapy Response
with Targeted Antibody Therapy Against Death Receptor 5
|
 |
|
Eric Holland, MD, PhD
|
|
Memorial Sloan-Kettering Cancer Center
|
|
Proteomic Serum Marker for Gliomas
|
 |
|
Paul Mischel, MD
|
|
University of California
Los Angeles
|
|
Pathway Profiling of Glioblastoma: Identification of Molecular
Correlates of Sensitivity to EGFR Inhibitors
|
 |
|
Charles Sawyers, MD
|
|
University of California
Los Angeles
|
|
Identification of Activated Kinases in Glioblastoma
Multiforme
|
 |
|
WK Alfred Yung, MD
|
|
MD Anderson
Cancer Center
|
|
Novel PTEN/PI3K Pathway Inhibitors for Glioblastoma Therapy
|
|
 |
|
|
|
 |